A direct oral anticoagulant (DOAC)
Dabigatran
A direct oral anticoagulant ("blood thinner") that reduces the risk of stroke and clots, and has its own specific reversal treatment.
What is Dabigatran?
Dabigatran is a direct oral anticoagulant (DOAC), a modern 'blood-thinning' medicine. It is used to reduce the risk of stroke in people with the irregular heartbeat atrial fibrillation, and to treat and prevent blood clots in the legs and lungs.
Education and reference only. This is a plain-language guide to Dabigatran — it deliberately contains no doses. Doses depend on the person, the brand and the reason for treatment, and belong with your prescriber. Always check the BNF, the product labelling (SmPC) and follow medical advice.
What it is
Dabigatran is a direct oral anticoagulant (DOAC) — a modern "blood-thinning" medicine. It is used to reduce the risk of stroke in people with the irregular heart rhythm atrial fibrillation, and to treat and prevent clots in the legs and lungs (venous thromboembolism). Unlike older warfarin, it does not need regular clotting blood tests or careful diet control. A distinctive feature is that it has its own specific antidote (idarucizumab) that can reverse its effect quickly in an emergency. It is sold as Pradaxa. It is not suitable for people with mechanical (artificial) heart valves.
How it works
Blood clots form through a chain of steps that ends in a substance called thrombin, which knits the clot together. Dabigatran is a "direct thrombin inhibitor": it blocks thrombin itself, the final common step, so clots are far less likely to form. By keeping the blood less prone to clotting, it lowers the chance of a stroke in atrial fibrillation and of clots forming or spreading in the veins. Because thrombin is so central to clotting, its effect is predictable enough not to need routine monitoring tests.
Company & origin
Originated / developed by: Boehringer Ingelheim.
Dabigatran (as the prodrug dabigatran etexilate) was developed by Germany's Boehringer Ingelheim, an oral direct thrombin inhibitor first approved in the EU in 2008 and by the US FDA in October 2010, marketed as Pradaxa.
What it treats
Conditions Dabigatran is used for
Practical use
How to take Dabigatran
General, dose-free guidance — always follow your prescriber's and the leaflet's specific instructions.
- Usually taken twice a day; try to keep to regular times.
- Swallow the capsule whole with water and do not open, chew or crush it, as this changes how much is absorbed.
- Keep the capsules in their original blister pack until you take them, as they are sensitive to moisture.
- Watch for and report unusual bruising, nosebleeds, blood in urine or stools, or any bleeding that will not stop.
- Do not stop without medical advice, as this can sharply raise the risk of a clot or stroke.
- Tell any doctor, dentist or pharmacist that you take an anticoagulant before procedures or new medicines.
Weighing it up
Advantages & disadvantages of Dabigatran
Advantages
- Effective at preventing strokes and clots, with a fixed dosing schedule.
- Does not need the regular blood-level monitoring that warfarin requires.
- Fewer interactions with food and alcohol than warfarin.
- Has a specific reversal treatment available in emergencies if serious bleeding occurs.
Disadvantages
- Like all anticoagulants, it increases the risk of bleeding, which can be serious.
- Must be taken twice daily and consistently, as missed doses reduce protection quickly.
- Can cause indigestion or stomach upset in some people.
- Not suitable for everyone, including those with significantly reduced kidney function.
Practical use
Good to know
The most important risk is bleeding, so report unusual bruising, blood in the urine or stools, black stools, or any heavy or prolonged bleeding. A practical quirk of dabigatran is that the capsules must be kept in their original blister pack or bottle and not transferred into a pill organiser, because they absorb moisture and can spoil. The capsules are swallowed whole. Kidney function matters, as the medicine is cleared by the kidneys, and it is not used with mechanical heart valves. If a specialist needs to reverse it urgently, the antidote idarucizumab is available.
Who should not take it / use with caution
- People with active or high-risk bleeding, or a recent bleeding stroke.
- People with significantly reduced kidney function (the kidneys clear it), and those with a mechanical (artificial) heart valve.
- Pregnancy and breastfeeding, and used with care alongside other medicines that increase bleeding risk.
Monitoring
- Kidney function (before starting and periodically)
- Signs of bleeding or anaemia
- A regular review of whether the medicine is still needed and tolerated
Side effects
- Bleeding or bruising more easily than usual — from minor (nosebleeds, gum bleeding) to, less often, more serious bleeding.
- Indigestion or stomach discomfort, which is more common with dabigatran than some other DOACs.
- Rarely, serious internal bleeding — sudden severe headache, weakness, blood in urine or stools, black stools or coughing/vomiting blood needs emergency care.
Key interactions
- Other medicines that thin the blood or affect clotting — such as aspirin, antiplatelets, other anticoagulants and some NSAID painkillers — add to bleeding risk.
- Certain medicines raise or lower dabigatran levels (for example some heart-rhythm drugs, certain antifungals and some others), so combinations are checked carefully.
- Always have new medicines, including those bought over the counter, checked by a pharmacist.
Available as: Capsules, which must be swallowed whole and kept in their original packaging.
Answers
Dabigatran: frequently asked questions
Why must I keep dabigatran in its original packaging?
Dabigatran capsules absorb moisture from the air, which can stop them working properly. For this reason they must stay in their original blister pack or bottle and must not be put into a weekly pill organiser or dosette box. If you find this hard to manage, ask your pharmacist for advice rather than transferring them.
Does dabigatran have an antidote like a reversal treatment?
Yes. Dabigatran has a specific antidote called idarucizumab, given in hospital, which can rapidly reverse its blood-thinning effect — for example before emergency surgery or if there is serious bleeding. This is a reassuring feature, though everyday safety still rests on taking it correctly and reporting bleeding.
Why can't dabigatran be used with a mechanical heart valve?
Studies found that DOACs like dabigatran did not protect mechanical (artificial) heart valves from clots as well as warfarin, and were linked to more problems. People with mechanical valves therefore stay on warfarin with its regular blood tests. Always tell any prescriber if you have an artificial heart valve.
What should I do if I notice bleeding or bruising?
Minor effects like the odd nosebleed or easy bruising are common; mention them at your next review. But heavy, prolonged or unusual bleeding — blood in the urine or stools, black stools, coughing or vomiting blood, or a sudden severe headache — needs urgent medical attention, as it can signal serious bleeding.
What is the difference between dabigatran and Pradaxa?
They are the same medicine — dabigatran is the generic (active-ingredient) name and Pradaxa is the brand name. The active ingredient is identical.
The wider class
About DOACs (anticoagulants)
Dabigatran belongs to the doacs (anticoagulants) class. For how the class as a whole works, its shared safety principles and monitoring, see the full guide.
Browse by body system
Authoritative sources
- BNF: Dabigatran etexilate.
- electronic Medicines Compendium (SmPC): Pradaxa.
- NICE CKS: Dabigatran.
Building a medicines information resource?
We create evidence-led, dose-free drug and formulary references for teams.